Merck Financial Statements
Merck Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
Merck Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 18,502.0 | 12,690.0 | 10,594.0 |
| Gross Profit ($ mil.) | 11,195.0 | 8,285.0 | 6,897.0 |
| Operating Income ($ mil.) | 2,585.0 | (970.0) | 1,655.0 |
| Total Net Income ($ mil.) | 1,903.0 | (1,473.0) | 1,121.0 |
| Diluted EPS (Net Income) | 1.07 | (1.04) | 0.71 |
Merck Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Jun 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 4,499.0 | 4,647.0 | 4,647.0 |
| Gross Profit ($ mil.) | 2,780.0 | 3,027.0 | 3,027.0 |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | 515.0 | 671.0 | 671.0 |
| Diluted EPS (Net Income) | 0.29 | 0.38 | 0.38 |
Merck Stock Quote & Chart
| 11/03/09 16:02:39 EST •
NYSE •
28.15
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Merck Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.55 | 2.65 | 7.00 |
| Price/Earnings Ratio | 18.21 | 16.81 | 25.45 |
| Price/Book Ratio | 4.44 | 2.88 | 6.74 |
| Price/Cash Flow Ratio | 13.37 | 10.14 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Merck Financial Ratios
Merck Competitive Intelligence
| Bayer AG | GlaxoSmithKline | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 46,397.9 | 35,244.6 | 48,296.0 |
| Employees | 108,600 | 99,003 | 81,800 |
| Market Cap ($ mil.) | 36,688.5 | 114,528.4 | 114,870.4 |
Competitive Landscape



